PAQR5 and neoplasm: No significant correlation was found with CD8+/CD4+ T cells or tumor purity (Figure 7), implying that antigen-presenting cells (APCs) in KIRC with low PAQR5 expression may be less expressed and unable to respond to the antitumor immune response, resulting in immune dysfunction.